AAAAAA

   
Results: 1-16 |
Results: 16
REDUCTION IN SIV REPLICATION IN RHESUS-MACAQUES INFUSED WITH AUTOLOGOUS LYMPHOCYTES ENGINEERED WITH ANTIVIRAL GENES (VOL 4, PG 181, 1998)
Authors: DONAHUE RE BUNNELL BA ZINK MC METZGER ME WESTRO RP KIRBY MR UNANGST T CLEMENTS JE MORGAN R
Citation: Re. Donahue et al., REDUCTION IN SIV REPLICATION IN RHESUS-MACAQUES INFUSED WITH AUTOLOGOUS LYMPHOCYTES ENGINEERED WITH ANTIVIRAL GENES (VOL 4, PG 181, 1998), Nature medicine, 4(5), 1998, pp. 633-633
REDUCTION IN SIV REPLICATION IN RHESUS MACAQUES INFUSED WITH AUTOLOGOUS LYMPHOCYTES ENGINEERED WITH ANTIVIRAL GENES
Authors: DONAHUE RE BUNNELL BA ZINK MC METZGER ME WESTRO RP KIRBY MR UNANGST T CLEMENTS JE MORGAN RA
Citation: Re. Donahue et al., REDUCTION IN SIV REPLICATION IN RHESUS MACAQUES INFUSED WITH AUTOLOGOUS LYMPHOCYTES ENGINEERED WITH ANTIVIRAL GENES, Nature medicine, 4(2), 1998, pp. 181-186
TARGETED TRANSDUCTION OF CD34(-EXPRESSING RETROVIRUS YIELDS PARTIAL ANTI-HIV PROTECTION OF PROGENY MACROPHAGES() CELLS BY TRANSDOMINANT NEGATIVE REV)
Authors: DAVIS BR SAITTA FP BAUER G BUNNELL BA MORGAN RA SCHWARTZ DH
Citation: Br. Davis et al., TARGETED TRANSDUCTION OF CD34(-EXPRESSING RETROVIRUS YIELDS PARTIAL ANTI-HIV PROTECTION OF PROGENY MACROPHAGES() CELLS BY TRANSDOMINANT NEGATIVE REV), Human gene therapy, 9(8), 1998, pp. 1197-1207
GENE-THERAPY FOR INFECTIOUS-DISEASES
Authors: BUNNELL BA MORGAN RA
Citation: Ba. Bunnell et Ra. Morgan, GENE-THERAPY FOR INFECTIOUS-DISEASES, Clinical microbiology reviews, 11(1), 1998, pp. 42
DEVELOPMENT OF IMPROVED ADENOSINE-DEAMINASE RETROVIRAL VECTORS
Authors: ONODERA M NELSON DM YACHIE A JAGADEESH GJ BUNNELL BA MORGAN RA BLAESE RM
Citation: M. Onodera et al., DEVELOPMENT OF IMPROVED ADENOSINE-DEAMINASE RETROVIRAL VECTORS, Journal of virology, 72(3), 1998, pp. 1769-1774
EFFICIENT IN-VIVO MARKING OF PRIMARY CD4(-LYMPHOCYTES IN NONHUMAN-PRIMATES USING A GIBBON APE LEUKEMIA VIRUS-DERIVED RETROVIRAL VECTOR() T)
Authors: BUNNELL BA METZGER M BYRNE E MORGAN RA DONAHUE RE
Citation: Ba. Bunnell et al., EFFICIENT IN-VIVO MARKING OF PRIMARY CD4(-LYMPHOCYTES IN NONHUMAN-PRIMATES USING A GIBBON APE LEUKEMIA VIRUS-DERIVED RETROVIRAL VECTOR() T), Blood, 89(6), 1997, pp. 1987-1995
GENE-THERAPY FOR AIDS
Authors: BUNNELL BA MORGAN RA
Citation: Ba. Bunnell et Ra. Morgan, GENE-THERAPY FOR AIDS, Molecules and cells, 6(1), 1996, pp. 1-12
GENE-THERAPY FOR HIV-INFECTION
Authors: BUNNELL BA MORGAN RA
Citation: Ba. Bunnell et Ra. Morgan, GENE-THERAPY FOR HIV-INFECTION, Medicamentos de actualidad, 32(3), 1996, pp. 209-224
IN-VIVO PROTECTION FROM SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION FOLLOWING GENE-TRANSFER OF AN ANTISENSE TAT REV RETROVIRAL VECTOR INTO RHESUS CD4+ PERIPHERAL-BLOOD LYMPHOCYTES/
Authors: BUNNELL BA METZGER ME BYRNE ER CLEMENTS JE MORGAN RA DONAHUE RE
Citation: Ba. Bunnell et al., IN-VIVO PROTECTION FROM SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION FOLLOWING GENE-TRANSFER OF AN ANTISENSE TAT REV RETROVIRAL VECTOR INTO RHESUS CD4+ PERIPHERAL-BLOOD LYMPHOCYTES/, Blood, 88(10), 1996, pp. 1935-1935
TRANSDUCTION AND TRANSPLANTATION OF NONHUMAN PRIMATE CD34-VIRUS PACKAGING CELL-LINE, PG13 - RESTRICTED EXPRESSION OF THE GIBBON APE LEUKEMIA-VIRUS RECEPTOR TO A SUBSET OF CD34+ CELLS THAT ARE SMALL IN SIZE ANDEXPRESS BOTH CD38 AND THY-1( CELLS USING THE GIBBON APE LEUKEMIA)
Authors: BUNNELL BA LEELIN SQ BYRNE ER METZGER ME AGRICOLA BA MORGAN RA DONAHUE RE
Citation: Ba. Bunnell et al., TRANSDUCTION AND TRANSPLANTATION OF NONHUMAN PRIMATE CD34-VIRUS PACKAGING CELL-LINE, PG13 - RESTRICTED EXPRESSION OF THE GIBBON APE LEUKEMIA-VIRUS RECEPTOR TO A SUBSET OF CD34+ CELLS THAT ARE SMALL IN SIZE ANDEXPRESS BOTH CD38 AND THY-1( CELLS USING THE GIBBON APE LEUKEMIA), Blood, 88(10), 1996, pp. 2567-2567
HIGH-EFFICIENCY RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN PERIPHERAL-BLOOD LYMPHOCYTES FOR HIV-1 GENE-THERAPY
Authors: BUNNELL BA MUUL LM BLAESE RM MORGAN RA
Citation: Ba. Bunnell et al., HIGH-EFFICIENCY RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN PERIPHERAL-BLOOD LYMPHOCYTES FOR HIV-1 GENE-THERAPY, AIDS research and human retroviruses, 11, 1995, pp. 156-156
OPTIMIZATION OF TRANSDUCTION EFFICIENCY OF HUMAN CD4-BLOOD LYMPHOCYTES( PERIPHERAL)
Authors: BUNNELL BA MORGAN RA
Citation: Ba. Bunnell et Ra. Morgan, OPTIMIZATION OF TRANSDUCTION EFFICIENCY OF HUMAN CD4-BLOOD LYMPHOCYTES( PERIPHERAL), Journal of cellular biochemistry, 1995, pp. 403-403
HIGH-EFFICIENCY RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN AND NONHUMAN PRIMATE PERIPHERAL-BLOOD LYMPHOCYTES
Authors: BUNNELL BA MUUL LM DONAHUE RE BLAESE RM MORGAN RA
Citation: Ba. Bunnell et al., HIGH-EFFICIENCY RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN AND NONHUMAN PRIMATE PERIPHERAL-BLOOD LYMPHOCYTES, Proceedings of the National Academy of Sciences of the United Statesof America, 92(17), 1995, pp. 7739-7743
IN-VIVO GENE-TRANSFER INTO NONHUMAN PRIMATE CD34(-VIRUS PACKAGING CELL-LINE, PG13() CELLS USING THE GIBBON APE LEUKEMIA)
Authors: BUNNELL BA MORGAN RA BYRNE ER AGRICOLA BA METZGER ME SELLERS SE DONAHUE RE
Citation: Ba. Bunnell et al., IN-VIVO GENE-TRANSFER INTO NONHUMAN PRIMATE CD34(-VIRUS PACKAGING CELL-LINE, PG13() CELLS USING THE GIBBON APE LEUKEMIA), Blood, 86(10), 1995, pp. 950-950
GENETIC-MODIFICATION OF STEM PROGENITOR CELLS TO PROTECT MACROPHAGE PROGENY FROM HIV-INFECTION/
Authors: DAVIS BR BAUER G SAITTA FP BUNNELL BA MORGAN RA SCHWARTZ DH
Citation: Br. Davis et al., GENETIC-MODIFICATION OF STEM PROGENITOR CELLS TO PROTECT MACROPHAGE PROGENY FROM HIV-INFECTION/, Blood, 86(10), 1995, pp. 1140-1140
HIGH-EFFICIENCY GENE-TRANSFER INTO NONHUMAN PRIMATE LYMPHOCYTES PERMITS TESTING OF ANTI-HIV GENE-THERAPY STRATEGIES IN-VIVO
Authors: BUNNELL BA METZGER ME CLEMENTS J MORGAN RA DONAHUE RE
Citation: Ba. Bunnell et al., HIGH-EFFICIENCY GENE-TRANSFER INTO NONHUMAN PRIMATE LYMPHOCYTES PERMITS TESTING OF ANTI-HIV GENE-THERAPY STRATEGIES IN-VIVO, Blood, 86(10), 1995, pp. 1171-1171
Risultati: 1-16 |